Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To characterize the safety and efficacy of pregabalin in subjects with GAD at low and high doses relative to placebo and lorazepam following 3 and 6 months of treatment.
Critère d'inclusion
- Generalized Anxiety Disorder (GAD)